Data / Drug companies / Aurolife Pharma, LLC
Aurolife Pharma, LLC: 70 products in the FDA NDC directory, labeler code 13107
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Aurolife Pharma, LLC (labeler code 13107) lists 70 products in the FDA National Drug Code Directory, covering 22 finished drugs by generic name. By type: 70 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 14, 2026.
The request: Watch Aurolife Pharma, LLC (FDA labeler code 13107): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 13107
- Products in commercial distribution
- 70
- Packages
- 235
- Finished drugs by generic name
- 22
- Prescription products
- 70
- Over the counter products
- 0
- Controlled substance products
- Schedule II 37, Schedule III 4, Schedule IV 12
- Flagged as original packager
- 65 of 65 products that carry the flag
- Started marketing in the last 12 months
- 3
- Products with a marketing end date set
- 3
- Earliest marketing start
- July 17, 1987
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 70 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 70 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Hydrocodone bitartrate and acetaminophen | 6 | 37 |
| Clorazepate dipotassium | 6 | 8 |
| Oxycodone and acetaminophen | 4 | 32 |
| Paroxetine | 4 | 33 |
| Mirtazapine | 4 | 42 |
| Trazodone hydrochloride | 4 | 39 |
| Oxycodone hydrochloride | 3 | 36 |
| Methylphenidate hydrochloride | 3 | 39 |
| Phentermine hydrochloride | 3 | 26 |
| Acetaminophen and codeine phosphate | 3 | 24 |
| Lorazepam | 3 | 38 |
| Hydromorphone hydrochloride | 3 | 20 |
| Oxymorphone hydrochloride | 2 | 9 |
| Beclomethasone dipropionate | 2 | 3 |
| Oxycodone hydrochloride oral solution | 2 | 1 |
| Dextroamphetamine sulfate | 2 | 17 |
| Methadone hydrochloride | 2 | 21 |
| Glycopyrrolate | 2 | 64 |
| Amphetamine sulfate | 2 | 12 |
| Butalbital, acetaminophen and caffeine | 1 | 23 |
| Diclofenac sodium | 1 | 109 |
| Hydrocodone bitartrate and ibuprofen | 1 | 2 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 53 | 75.7% |
| Tablet, film coated | 9 | 12.9% |
| Solution | 3 | 4.3% |
| Capsule | 3 | 4.3% |
| Aerosol, metered | 2 | 2.9% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Beclomethasone Dipropionate | 13107-231 | Aerosol, metered | Generic drugs (ANDA) | September 14, 2026 |
| Beclomethasone Dipropionate | 13107-230 | Aerosol, metered | Generic drugs (ANDA) | September 14, 2026 |
| Phentermine hydrochloride | 13107-061 | Tablet | Generic drugs (ANDA) | April 10, 2026 |
| Clorazepate dipotassium | 13107-284 | Tablet | Generic drugs (ANDA) | September 23, 2023 |
| Clorazepate dipotassium | 13107-283 | Tablet | Generic drugs (ANDA) | September 23, 2023 |
| Clorazepate dipotassium | 13107-282 | Tablet | Generic drugs (ANDA) | September 23, 2023 |
| Glycopyrrolate | 13107-015 | Tablet | Generic drugs (ANDA) | February 28, 2023 |
| Glycopyrrolate | 13107-014 | Tablet | Generic drugs (ANDA) | February 28, 2023 |
| Diclofenac Sodium | 13107-269 | Solution | Generic drugs (ANDA) | February 3, 2023 |
| Lorazepam | 13107-085 | Tablet | Generic drugs (ANDA) | February 1, 2021 |
| Lorazepam | 13107-084 | Tablet | Generic drugs (ANDA) | February 1, 2021 |
| Lorazepam | 13107-083 | Tablet | Generic drugs (ANDA) | February 1, 2021 |
| Oxycodone Hydrochloride Oral Solution | 13107-262 | Solution | Generic drugs (ANDA) | January 27, 2020 |
| Oxycodone Hydrochloride Oral Solution | 13107-261 | Solution | Generic drugs (ANDA) | January 27, 2020 |
| Amphetamine Sulfate | 13107-260 | Tablet | Generic drugs (ANDA) | January 31, 2019 |
| Amphetamine Sulfate | 13107-259 | Tablet | Generic drugs (ANDA) | January 31, 2019 |
| Butalbital, Acetaminophen and Caffeine | 13107-075 | Capsule | Generic drugs (ANDA) | April 26, 2017 |
| Methylphenidate Hydrochloride | 13107-382 | Tablet | Generic drugs (ANDA) | April 11, 2017 |
| Methylphenidate Hydrochloride | 13107-381 | Tablet | Generic drugs (ANDA) | April 11, 2017 |
| Methylphenidate Hydrochloride | 13107-380 | Tablet | Generic drugs (ANDA) | April 11, 2017 |
| Phentermine | 13107-106 | Capsule | Generic drugs (ANDA) | March 20, 2017 |
| Phentermine | 13107-105 | Capsule | Generic drugs (ANDA) | March 20, 2017 |
| Hydrocodone Bitartrate and Ibuprofen | 13107-004 | Tablet, film coated | Generic drugs (ANDA) | June 2, 2016 |
| Hydromorphone hydrochloride | 13107-109 | Tablet | Generic drugs (ANDA) | May 17, 2016 |
| Hydromorphone hydrochloride | 13107-108 | Tablet | Generic drugs (ANDA) | May 17, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.